Valuation: Integra LifeSciences Holdings Corporation

Market Cap 1.08B 982M 909M 823M 1.54B 101B 1.62B 10.99B 4.36B 54.42B 4.05B 3.96B 172B P/E 2026 *
28.3x
P/E 2027 * 12.6x
Enterprise Value 2.89B 2.63B 2.43B 2.2B 4.13B 270B 4.32B 29.42B 11.67B 146B 10.83B 10.6B 461B EV / Sales 2026 *
1.76x
EV / Sales 2027 * 1.42x
Free-Float
72.33%
Yield 2026 *
-
Yield 2027 * -
1 day-2.24%
1 week-8.26%
Current month+6.27%
1 month+2.57%
3 months-22.79%
6 months-3.97%
Current year+9.10%
1 week 13.4
Extreme 13.395
14.62
1 month 11.57
Extreme 11.57
15.25
Current year 8.7
Extreme 8.7
20.49
1 year 8.7
Extreme 8.7
20.49
3 years 8.7
Extreme 8.7
45.42
5 years 8.7
Extreme 8.7
69.95
10 years 8.7
Extreme 8.7
77.4
Manager TitleAgeSince
Chief Executive Officer 64 30/04/2026
Director of Finance/CFO 54 27/06/2023
Chief Tech/Sci/R&D Officer - 30/06/2024
Director TitleAgeSince
Chairman 64 02/01/2012
Director/Board Member 81 31/12/1991
Director/Board Member 65 31/12/2005
Date Insider Type Main position Quantity % Market Cap. Importance
01/10/26 Other

Executive/Senior Manager

67,801 0.0871%
17/09/26 Other

Company Secretary

26,838 0.0345%
01/09/26 Tax

Head of Human Resources

-1,455 0.0019%
Change 5-day change 1-year change 3-year change Capi.($)
-2.24%-8.26%+18.65%-65.03% 1.08B
-0.58%-4.96%-20.10%+4.34% 181B
-0.11%-0.98%-0.19%+34.58% 123B
-1.59%-1.79%-12.92%+8.57% 121B
-2.21%-3.15%-43.22%-1.44% 91.11B
-2.03%-2.47%-5.64%+75.00% 66.47B
-1.57%-0.86%+10.58%-8.83% 58.86B
-1.26%-1.84%+2.90%+48.73% 55.03B
+0.38%-1.22%+2.17%+39.18% 48.88B
+1.60%+6.46%+5.64%+1.34% 35.5B
Average -0.96%-0.88%-4.21%+13.64% 78B
Weighted average by Cap. -0.94%-1.13%-10.78%+19.17%

Financials

2026 *2027 *
Net sales 1.64B 1.5B 1.39B 1.25B 2.35B 154B 2.46B 16.76B 6.65B 82.98B 6.17B 6.04B 263B 1.67B 1.53B 1.41B 1.28B 2.4B 156B 2.51B 17.07B 6.77B 84.52B 6.28B 6.15B 268B
Net income 35.57M 32.41M 30M 27.14M 50.91M 3.32B 53.28M 363M 144M 1.8B 133M 131M 5.69B 69.57M 63.39M 58.68M 53.08M 99.57M 6.5B 104M 709M 281M 3.51B 261M 256M 11.12B
Net Debt 1.81B 1.65B 1.52B 1.38B 2.59B 169B 2.71B 18.43B 7.31B 91.21B 6.78B 6.64B 289B 1.31B 1.19B 1.1B 996M 1.87B 122B 1.96B 13.31B 5.28B 65.9B 4.9B 4.8B 209B
Projected Income Statement - Annual - Integra LifeSciences Holdings Corporation
Logo Integra LifeSciences Holdings Corporation
Integra LifeSciences Holdings Corporation is a global medical technology company. It manufactures and sells medical technologies and products in two segments: Codman Specialty Surgical (CSS) and Tissue Technologies (TT). CSS consists of technologies and instrumentations used for specialties, such as neurosurgery, neurocritical care, and otolaryngology. CSS neurosurgical business includes a portfolio of brands, which are used for the management of multiple disease states, including brain tumors, traumatic brain injury, hydrocephalus and other neurological conditions. It provides instruments that are used in precision, specialty and general surgical procedures. TT includes Wound Reconstruction and Care business, which sells offerings, such as skin and wound repair, plastics and surgical reconstruction products and nerve and tendon repair products. Its products include CUSA Platform, Codman Neurosurgical Accessories, DuraGen Dural Graft Matrix, DuraSeal Dural Sealant System and others.
Employees
4,427
Date Price Change Volume
19/11/26 US$13.55 -2.24% 784,015
18/11/26 US$13.86 +2.29% 575,208
17/11/26 US$13.55 -3.08% 1,237,673
16/11/26 US$13.98 -2.92% 706,387
13/11/26 US$14.40 +0.35% 648,838
Trader
Investor
Global
Quality
ESG MSCI
BBB
MarketScreener Ratings - Integra LifeSciences Holdings Corporation
Sell
Consensus
Buy
Mean consensus
HOLD
Number of Analysts
12
Last Close Price
13.55USD
Average target price
15.67USD
Spread / Average Target
+15.62%
  1. Stock Market
  2. Stocks
  3. IART Stock